IMMUNITOR
Since 2000, Immunitor has been developing orally-delivered immunotherapies for a number of serious diseases affecting the world. Immunitor products are used as means of preventing and/or treating viral infections such as HIV, hepatitis B and C, influenza, tuberculosis, broad-spectrum bacterial and fungal infections, cancer; and atherosclerosis/obesity. Immunitor Inc. is the global holding corporation for Immunitor product and manufacturing rights and assets. Currently, Immunitor has GMP manufacturing capability in Thailand. Specific Immunitor products are registered in several Asian and African countries. Immunitor CEO is Dr. Aldar S. Bourinbaiar, the manufacturing plant is run by Mr. Vichai Jirathitikal. These two individuals are the respective main shareholders of the company.
IMMUNITOR
Industry:
Biotechnology Health Care Pharmaceutical Therapeutics
Founded:
2000-01-01
Address:
Chachoengsao, Chachoengsao, Thailand
Country:
Thailand
Website Url:
http://www.immunitor.com
Status:
Active
Technology used in webpage:
SPF Apache PHP DigiCert SSL CentOS Apache 2.2 RapidSSL Thickbox
Current Employees Featured
Vichai Jirathitikal Owner @ Immunitor
Owner
Aldar Bourinbaiar CEO @ Immunitor
CEO
2001-01-01
Founder
Official Site Inspections
http://www.immunitor.com Semrush global rank: 5.31 M Semrush visits lastest month: 1.56 K
- Host name: a2aa9ff50de748dbe.awsglobalaccelerator.com
- IP address: 15.197.148.33
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Immunitor"
Immunitor - Crunchbase Company Profile & Funding
Immunitor products are used as means of preventing and/or treating viral infections such as HIV, hepatitis B and C, influenza, tuberculosis, broad-spectrum bacterial and fungal infections, …See details»
Immunitor 2025 Company Profile: Valuation, Investors ... - PitchBook
Immunitor General Information Description. Manufacturer and developer of immunotherapies and therapeutic vaccines intended for the treatment of tuberculosis. The company is engaged in …See details»
aldar bourinbaiar - Chief Executive Officer - IMMUNITOR Ltd
Chief Executive Officer at IMMUNITOR Ltd. · Experienced Chief Executive Officer skilled in Bioinformatics, Protein Chemistry, Vaccines, Oncology, and Molecular Biology. Strong …See details»
Top 20 Pharmaceutical Companies In Thailand In 2025
Mega Lifesciences is a maverick organization founded in 1982. From two machines and few people to three world class factories in Thailand, this company devoted much its energy in …See details»
Immunitor, Inc. (Immunitor, Inc.) - 药物管线_专利_临床试验_投融营 …
Keytruda for example, aside from its high cost, only has a 10% positive response rate in 12-month HCC treatments. Breakthrough Liver Cancer Treatment Immunitor V5 has demonstrated …See details»
อิมมูนิเตอร์ ประเทศไทย จำกัด - Home
อิมมูนิเตอร์ ประเทศไทย จำกัด immunitor technologySee details»
IMMUNITOR Ltd. | LinkedIn
IMMUNITOR Ltd. | 43 seguidores no LinkedIn. Immunitor's proprietary technology enables us to formulate any vaccine as an oral pill. | Immunitor's proprietary technology enables us to …See details»
Immunitor Email verification & Email checker | NeverBounce
Since 2000 Immunitor has been developing orally-delivered immunotherapies for a number of serious diseases affecting the world. Immunitor products are used as means of preventing …See details»
อิมมูนิเตอร์ ประเทศไทย จำกัด - Publications
Phase 2 Trial of V-5 Immunitor (V5) in Patients with Chronic Hepatitis C Co-infected with HIV and Mycobacterium Tuberculosis. Adjunct oral immunotherapy in patients with re-treated, …See details»
Immunitor | Competitors - Tracxn
Details about top competitor companies of Immunitor. Details about top competitor companies of Immunitor Toggle navigation. Solutions. By Investment Industry. Venture Capital Funds …See details»
Immune approaches in tuberculosis therapy: a brief overview
1 Immunitor Inc., Vancouver, BC, Canada. aldar@immunitor.com; PMID: 22397570 DOI: 10.1586/eri.12.1 Abstract TB is typically caused by Mycobacterium tuberculosis, a symbiotic …See details»
Mycobacterium vaccae vaccine - Immune Network - AdisInsight
Alternative Names: Heat-inactivated M. vaccae pill; tableted heat-inactivated mycobacterium vaccae; Tubivac; V-7; V-7 Immunitor Latest Information Update: 22 Mar 2022 Price : $50 * Buy …See details»
อิมมูนิเตอร์ ประเทศไทย จำกัด - Administrators information
ผมเชื่อว่า " พื้นฐานสุขภาพดีเริ่มต้นด้วยการทานอาหารให้ครบ5หมู่และอย่าลืมทานผลิตภัณฑ์ของอิมมูนิเตอร์ …See details»
ข้อมูล บริษัท อิมมูนิเตอร์ (ประเทศไทย) จำกัด
IMMUNITOR (THAILAND) COMPANY LIMITED ทะเบียน:0245549000464 เป็นธุรกิจผลิตและจำหน่ายอาหารเสริมสุขภาพ …See details»
Linkage Tool for the COVID-19 Rapid Response Funding - CIHR
Aldar@immunitor.com 1-301-476-0930. Immunitor website. British Columbia: ... I would love to partner with a CIHR-eligible organization to assist with either evidence synthesis or …See details»
IMMUNITOR MARKETING COMPANY LIMITED - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for IMMUNITOR MARKETING COMPANY LIMITED of BANG BON, BANGKOK. Get the latest business …See details»
肝癌晚期突破性免疫治疗试验 - MedSci.cn
2017年4月，在位于不列颠哥伦比亚的温哥华，Immunitor 公司欣然报道该公司试验成功，试验结果表明其每日一次的口服免疫疫苗 -- hepcortespenlisimut-L (Hepko-V5) 可安全且高效的对晚 …See details»
Hepcortespenlisimut-L(Hepcortespenlisimut-L) - _专利_临床_研发
Hepcortespenlisimut-L: 一种免疫刺激剂药物，由Immunitor, Inc. (Immunitor, Inc.)公司最早进行研发，目前全球最高研发状态为无进展，作用机制: 免疫刺激剂，治疗领域: 肿瘤,消化系统疾病, …See details»
Immunotherapy by ImmunityBio - Cancer Vaccine Research
Mar 13, 2025 Opportunities for Trial Investigators The broad therapeutic potential and demonstrated safety of ImmunityBio’s immune-enhancing IL-15 superagonist Anktiva (N-803), …See details»
Pilot trial of oral therapeutic HIV vaccine, V-1 Immunitor, on HIV …
Jan 1, 2010 Europe PMC is an archive of life sciences journal literature.See details»